- Deep brain stimulation (DBS) solutions, involving implanted medical devices that deliver electrical impulses to specific brain areas, are increasingly vital components of modern neurological treatment for various movement disorders and psychiatric conditions. Their growing importance stems from enhanced symptom control, potential for improved quality of life, and precise targeting capabilities
- The escalating demand for deep brain stimulation solutions is primarily fueled by the rising global prevalence of neurological disorders, an aging population, and continuous advancements in neurostimulation technology. A growing preference for effective, long-term therapeutic options also contributes significantly to market expansion
- North America dominates the deep brain stimulation market with the largest revenue share of 50.55% in 2024, characterized by advanced healthcare infrastructure, high prevalence of target neurological disorders, and a strong presence of key industry players
- Asia-Pacific is expected to be the fastest-growing region in the deep brain stimulation market during the forecast period, with a projected CAGR of 11.4% from 2025 to 2030. This growth is primarily due to increasing awareness of neurological conditions, improving healthcare access and infrastructure, and rising disposable incomes in key economies within the region
- The dual channel deep brain stimulator segment dominates the deep brain stimulation market with a market share of 56.9% in 2024, driven by its increasing adoption for providing bilateral therapy and enhanced precision in managing complex neurological disorders
